Ken A. Keller
Direttore/Membro del Consiglio presso Onconome, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| J. Carter McNabb | M | 52 |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | - |
| H. Raymond Cairncross | M | - |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | 23 anni |
| John J. Hagenbuch | M | 72 |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | - |
| Gregory Demopulos | M | 65 |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | - |
| Io Dolka | F | - |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 5 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Ken A. Keller
- Contatti personali
